Perioperative management of pyoderma gangrenosum.


Journal

Journal of the American Academy of Dermatology
ISSN: 1097-6787
Titre abrégé: J Am Acad Dermatol
Pays: United States
ID NLM: 7907132

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 11 09 2019
revised: 02 01 2020
accepted: 03 01 2020
pubmed: 14 1 2020
medline: 24 2 2021
entrez: 14 1 2020
Statut: ppublish

Résumé

Pyoderma gangrenosum (PG) classically presents with an acute inflammatory stage, characterized by rapid evolution of painful ulcerations. The pathergy associated with PG lesions complicates disease management. Although PG is commonly treated with immunosuppression, some patients have refractory noninflammatory ulcers. In this subpopulation, there are case reports of successful surgical treatment. However, there is no consensus on optimal perioperative treatment for patients with PG undergoing surgery of any kind, PG related or otherwise. Therefore, we conducted a comprehensive literature review describing perioperative management practices and risk factors that may predict response to surgical intervention. We identified 126 cases of surgical intervention in patients with active PG; among these, only 16.7% experienced postoperative disease progression. No perioperative treatments or clinical risk factors were identified as statistically significant predictors of disease recurrence. Although limited by case series design and publication bias, this study is a valuable means of hypothesis generation for this rare condition.

Identifiants

pubmed: 31927079
pii: S0190-9622(20)30035-9
doi: 10.1016/j.jaad.2020.01.002
pii:
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

369-374

Informations de copyright

Copyright © 2020 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Carter K Haag (CK)

Department of Dermatology, Oregon Health & Science University, Center for Health & Healing, Portland, Oregon.

Lindsay Bacik (L)

Department of Dermatology, Penn State University School of Medicine, Hershey, Pennsylvania.

Emile Latour (E)

Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.

Daniel C Morse (DC)

Department of Dermatology, McGovern School of Medicine at the University of Texas Health Sciences Center, Houston, Texas.

Nicole M Fett (NM)

Department of Dermatology, Oregon Health & Science University, Center for Health & Healing, Portland, Oregon.

Alex G Ortega-Loayza (AG)

Department of Dermatology, Oregon Health & Science University, Center for Health & Healing, Portland, Oregon. Electronic address: ortegalo@ohsu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH